Kathleen Welsh-Bohmer

Dr. Kathleen Welsh-Bohmer


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2006 in International Psychogeriatrics
Verified
Journal Article
Open access
PDF file
JLJung Sik Lee
Jung Sik Lee
GPGuy G. Potter
Guy G. Potter
HWH. Ryan Wagner
H. Ryan Wagner
KWKathleen Welsh-Bohmer
Kathleen Welsh-Bohmer
DSDavid C. Steffens
David C. Steffens
Background: Cognitive impairment often occurs with geriatric depression and impairments may persist despite remission of depression. Although clinical definitions of mild cognitive impairment (MCI) have typically excluded depression, a neuropsychological model of MCI in depression has utility for identifying individuals whose cognitive impairments may persist or progress to dementia.Methods: At baseline and 1-year follow-up, 67 geriatric patients with depression had a comprehensive clinical examination that included depression assessment and neuropsychological testing. We defined MCI by a neuropsychological algorithm and examined the odds of MCI classification at Year 1 for remitted depressed individuals with baseline MCI, and examined clinical, functional and genetic factors associated with MCI.Results: Fifty-four percent of the sample had MCI at baseline. Odds of MCI classification at Year 1 were four times greater among patients with baseline MCI than those without. Instrumental activities of daily living were associated with MCI at Year 1, while age and APOE genotype was not.Conclusions: These results confirm previous observations that MCI is highly prevalent among older depressed adults and that cognitive impairment occurring during acute depression may persist after depression remits. Self-reported decline in functional activities may be a marker for persistent cognitive impairment, which suggests that assessments of both neuropsychological and functional status are important prognostic factors in the evaluation of geriatric depression.

1 July 2001 in Neuropsychological Rehabilitation
Verified
Journal Article
Closed access
DKDeborah C. Koltai
Deborah C. Koltai
KWKathleen Welsh-Bohmer
Kathleen Welsh-Bohmer
DSDonald E. Schmechel
Donald E. Schmechel

1 October 2004 in Behavioral Neuroscience
Verified
Journal Article
Closed access
KLKevin S. LaBar
Kevin S. LaBar
CCCraig A. Cook
Craig A. Cook
DTDana C. Torpey
Dana C. Torpey
KWKathleen Welsh-Bohmer
Kathleen Welsh-Bohmer
Fear conditioning has provided a useful model system for studying associative emotional learning, but the impact of healthy aging has gone relatively unexplored. The present study investigated fear conditioning across the adult life span in humans. A delay discrimination task was employed using visual conditioned stimuli and an auditory unconditioned stimulus. Awareness of the reinforcement contingencies was assessed in a postexperimental interview. Compared with young adult participants, middle-aged and older adults displayed reductions in unconditioned responding, discriminant conditioning, and contingency awareness. When awareness and overall arousability were taken into consideration, there were no residual effects of aging on conditioning. These results highlight the importance of considering the influence of declarative knowledge when interpreting age-associated changes in discriminative conditioned learning.

1 January 2009 in The Clinical Neuropsychologist
Verified
Journal Article
Closed access
KWKathleen Welsh-Bohmer
Kathleen Welsh-Bohmer
TØTruls Østbye
Truls Østbye
LSLinda Sanders
Linda Sanders
CPCarl F. Pieper
Carl F. Pieper
Kathleen HaydenKathleen Hayden
Kathleen Hayden
FGfor the Cache Country Study Group
for the Cache Country Study Group
The Cache County Study of Memory in Aging (CCMS) is an epidemiological study of Alzheimer's disease (AD), mild cognitive disorders, and aging in a population of exceptionally long-lived individuals (7th to 11th decade). Observation of population members without dementia provides an opportunity for establishing the range of normal neurocognitive performance in a representative sample of the very old. We examined neurocognitive performance of the normal participants undergoing full clinical evaluations (n = 507) and we tested the potential modifying effects of apolipoprotein E (APOE) genotype, a known genetic risk factor for the later development of AD. The results indicate that advanced age and low education are related to lower test scores across nearly all of the neurocognitive measures. Gender and APOE ϵ 4 both had negligible and inconsistent influences, affecting only isolated measures of memory and expressive speech (in case of gender). The gender and APOE effects disappeared once age and education were controlled. The study of this exceptionally long-lived population provides useful normative information regarding the broad range of “normal” cognition seen in advanced age. Among elderly without dementia or other cognitive impairment, APOE does not appear to exert any major effects on cognition once other demographic influences are controlled.

1 September 1997 in Neurology
Verified
Journal Article
Closed access
PDF file
KWKathleen Welsh-Bohmer
Kathleen Welsh-Bohmer
RMRichard C. Mohs
Richard C. Mohs
CERAD neuropsychological battery. Although the clinical presentation of AD varies from patient to patient, specific cognitive deficits inevitably appear, such as memory impairment, disorientation, loss of expressive and receptive language, and dyspraxia.4 Accordingly, the CERAD battery included tests to assess each of these cognitive domains.1 The verbal fluency test assesses language production by asking the patient to name as many animals as possible within 60 seconds.5 A shortened version of the Boston Naming Test6 asks patients to name objects shown in 15 line drawings (five words each of high, medium, and low frequency). Other tests include the Mini-Mental State Examination (MMSE)7; a 10-item word list memory, recall, and recognition test; constructional praxis;8 and delayed recall of the praxis items. The battery usually requires 20 to 30 minutes to administer.

31 May 2005 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
Kathleen HaydenKathleen Hayden
Kathleen Hayden
PZPeter P. Zandi
Peter P. Zandi
CLConstantine G. Lyketsos
Constantine G. Lyketsos
JTJoAnn T. Tschanz
JoAnn T. Tschanz
MNMaria C. Norton
Maria C. Norton
FIfor the Cache County Investigators
for the Cache County Investigators